Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.

被引:0
|
作者
Kocher, Florian
Seeber, Andreas
Weiss, Lukas
Romeder, Franz
Szkandera, Joanna
Kuhr, Thomas
Kostner, Susanne
Pichler, Petra
Jaeger, Thomas
Greil, Richard
Brodowicz, Thomas
机构
[1] Med Univ Innsbruck, Dept Internal Med Hematol & Oncol 5, Innsbruck, Austria
[2] Dept Internal Med V Hematol & Oncol, Innsbruck, Austria
[3] Paracelsus Med Univ, Salzburg Canc Res Inst, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, Salzburg, Austria
[4] Hosp Barmherzige Schwestern Linz, Internal Med Dept Med Oncol Hematol & Gastroenter, Linz, Austria
[5] Med Univ Graz, Div Clin Oncol, Graz, Austria
[6] Hosp Wels Grieskirchen, Dept Internal Med 4, Wels, Austria
[7] Hosp Schwaz, Dept Internal Med, Schwaz, Austria
[8] Univ Klinikum St Polten, St Polten, Austria
[9] Acad Teaching Hosp Feldkirch, Internal Med Med Oncol Hematol Gastroenterol & Rh, Feldkirch, Austria
[10] Paracelsus Med Univ, Ctr Oncol, Dept Internal Med Hematol Med Oncol Hemostaseol I, Salzburg, Austria
[11] Med Univ Vienna, Vienna, Austria
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e22550
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [31] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES FOR PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA RECEIVING SYSTEMIC THERAPY IN THE UNITED KINGDOM
    Mytelka, D. S.
    Lorenzo, M.
    Stafkey-Mailey, D.
    D'yachkova, Y.
    Nagar, S. P.
    Candrilli, S. D.
    Kaye, J. A.
    VALUE IN HEALTH, 2016, 19 (07) : A751 - A751
  • [32] Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study
    Oh, Chung Ryul
    Hong, Jung Yong
    Kim, Jee Hung
    Lee, Ji Sung
    Kim, Hyo Song
    Kim, Tae Won
    Ahn, Jin-Hee
    Kim, Jeong Eun
    TARGETED ONCOLOGY, 2020, 15 (04) : 485 - 493
  • [33] Contributions of Real-World Evidence and Real-World Data to Decision-Making in the Management of Soft Tissue Sarcomas
    Demetri, George D.
    Stacchiotti, Silvia
    ONCOLOGY, 2021, 99 (SUPPL 1) : 3 - 7
  • [34] Survival analysis of patients with recurrent or metastatic soft tissue sarcoma who were treated by cryoablation: A real-world retrospective study
    Wu, Qun
    Li, Jing
    Yang, Wuwei
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (07) : 1736 - 1741
  • [35] Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy
    Li, Shaoli
    Sun, Qunan
    Bai, Rui
    Wang, Youping
    Wang, Hui
    Chen, Haifeng
    Dong, Ying
    BMC CANCER, 2024, 24 (01)
  • [36] The real-world clinical outcomes and treatment patterns of patients with unresectable locally advanced or metastatic soft tissue sarcoma treated with anlotinib in the post-ALTER0203 trial era
    Zhang, Ren-Shu
    Liu, Jie
    Deng, Yao-Tiao
    Wu, Xin
    Jiang, Yu
    CANCER MEDICINE, 2022, 11 (11): : 2271 - 2283
  • [37] A nomogram to predict the prognosis of advanced soft tissue sarcoma patients treated with anlotinib: A real-world population-based study.
    Bin Wang
    Liu, Jie
    Zhang, Ren Shu
    Jiang, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Real-world data on cabozantinib in advanced osteosarcoma and Ewing sarcoma - A study of the Hellenic Group of Sarcoma and Rare Cancers
    Kokkali-Zervos, S.
    Ardavanis, A.
    Panousieris, M.
    Duran, J.
    Boukovinas, I.
    ANNALS OF ONCOLOGY, 2020, 31 : S984 - S984
  • [39] Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients
    Thana, Myuran
    Basappa, Naveen S.
    Ghosh, Sunita
    Kollmannsberger, Christian K.
    Heng, Daniel Y. C.
    Hansen, Aaron R.
    Graham, Jeffery
    Soulieres, Denis
    Reaume, Martin Neil
    Lalani, Aly-Khan A.
    Castonguay, Vincent
    Bjarnason, Georg A.
    Patenaude, Francois
    Breau, Rodney H.
    Pouliot, Frederic
    Kapoor, Anil
    Wood, Lori A.
    CLINICAL GENITOURINARY CANCER, 2022, 20 (03) : 210 - 218
  • [40] Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria
    Christine Deutschmann
    Rupert Bartsch
    Christian F Singer
    Daphne Gschwantler-Kaulich
    Michael Seifert
    Carmen Leser
    Maximilian Marhold
    Zsuzsanna Bago-Horvath
    Georg Pfeiler
    BMC Cancer, 22